Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin vs. Levofloxacin for H. pylori Eradication
NCT03021590Phase 4Withdrawn
- Sponsor
- Damascus Hospital
- Start
- Jun 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clarithromycin in Helicobacter pylori infection, sponsored by Damascus Hospital. Primary endpoint: Helicobacter pylori Eradication Rate at 6 weeks. Planned start Jun 2017; status: withdrawn.
02
Drugs
clarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03021590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03021590.